CollPlant Biotechnologies (CLGN) Other Non Operating Income (2018 - 2021)
CollPlant Biotechnologies (CLGN) posted Other Non Operating Income of -$42.0 million for Q3 2021, down 107592.31% on a QoQ basis from -$39000.0 in Q2 2021, and down 110.0% year-over-year from $420.0 million in Q3 2020.
CollPlant Biotechnologies (CLGN) Other Non Operating Income (2018 - 2021) Analysis & Trends
CollPlant Biotechnologies' Other Non Operating Income history runs 4 years deep, the most recent figure standing at -$42.0 million for Q3 2021.
- Quarterly Other Non Operating Income fell 110.0% year-over-year to -$42.0 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was -$49.8 million (down 155.85% YoY) and the FY2020 annual result came in at $181000.0, down 21.3% from the prior year.
- Other Non Operating Income was -$42.0 million for Q3 2021 at CollPlant Biotechnologies, down from -$39000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $511000.0 in Q4 2019 and bottomed at -$42.0 million in Q3 2021.
- A 4-year average of -$4.6 million and a median of -$65000.0 in 2020 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2019 — Other Non Operating Income jumped 755.13% — and 2020, when it slumped 51182.05%.
- CollPlant Biotechnologies' Other Non Operating Income stood at -$78000.0 in 2018, then soared by 755.13% to $511000.0 in 2019, then plunged by 1630.14% to -$7.8 million in 2020, then slumped by 437.15% to -$42.0 million in 2021.
- Business Quant data shows CLGN's Other Non Operating Income at -$42.0 million in Q3 2021, -$39000.0 in Q2 2021, and $67000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -42.00 Mn |
| Jun 30, 2021 | -39,000.00 |
| Mar 31, 2021 | 67,000.00 |
| Dec 31, 2020 | -7.82 Mn |
| Sep 30, 2020 | -20.00 Mn |
| Jun 30, 2020 | -65,000.00 |
| Mar 31, 2020 | 93,000.00 |
| Dec 31, 2019 | 511,000.00 |
| Sep 30, 2019 | -39,000.00 |
| Jun 30, 2019 | -111,000.00 |
| Mar 31, 2019 | -131,000.00 |
| Dec 31, 2018 | -78,000.00 |
| Sep 30, 2018 | -109,000.00 |
| Jun 30, 2018 | -40,000.00 |
| Mar 31, 2018 | 143,000.00 |